412 related articles for article (PubMed ID: 26529630)
1. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
[TBL] [Abstract][Full Text] [Related]
2. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of the three major variants of papillary thyroid carcinoma.
Xu J; Zhang Y; Liu J; Qiu S; Wang M
J Int Med Res; 2021 Feb; 49(2):300060520984618. PubMed ID: 33535844
[TBL] [Abstract][Full Text] [Related]
4. Impact of tall cell variant histology on predicting relapse and changing the management of papillary thyroid carcinoma patients.
Gunalp B; Okuyucu K; Ince S; Ayan A; Alagoz E
Hell J Nucl Med; 2017; 20(2):122-127. PubMed ID: 28697188
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
[TBL] [Abstract][Full Text] [Related]
6. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison.
Finnerty BM; Kleiman DA; Scognamiglio T; Aronova A; Beninato T; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2015 Apr; 22(4):1200-6. PubMed ID: 25297901
[TBL] [Abstract][Full Text] [Related]
7. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
[TBL] [Abstract][Full Text] [Related]
8. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
[TBL] [Abstract][Full Text] [Related]
9. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome.
Lang BH; Lo CY; Chan WF; Lam AK; Wan KY
World J Surg; 2006 May; 30(5):752-8. PubMed ID: 16680590
[TBL] [Abstract][Full Text] [Related]
10. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
[TBL] [Abstract][Full Text] [Related]
11. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis Reveals Dysregulation of the Mycobiome and Archaeome and Distinct Oncogenic Characteristics according to Subtype and Gender in Papillary Thyroid Carcinoma.
John D; Yalamarty R; Barakchi A; Chen T; Chakladar J; Li WT; Ongkeko WM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834564
[TBL] [Abstract][Full Text] [Related]
13. Prediction of novel target genes and pathways involved in tall cell variant papillary thyroid carcinoma.
Xia F; Jiang B; Chen Y; Du X; Peng Y; Wang W; Wang Z; Li X
Medicine (Baltimore); 2018 Dec; 97(51):e13802. PubMed ID: 30572540
[TBL] [Abstract][Full Text] [Related]
14. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
15. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases.
Eloy C; Santos J; Soares P; Sobrinho-Simões M
Virchows Arch; 2011 Sep; 459(3):265-76. PubMed ID: 21796448
[TBL] [Abstract][Full Text] [Related]
16. Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma.
Li F; Li W; Gray KD; Zarnegar R; Wang D; Fahey TJ
J Int Med Res; 2020 Nov; 48(11):300060520966491. PubMed ID: 33213252
[TBL] [Abstract][Full Text] [Related]
17. Papillary Thyroid Carcinomas with Tall Cell Features: An Intermediate Entity Between Classic and Tall Cell Subtypes.
Bikas A; Wong K; Pappa T; Ahmadi S; Wakefield CB; Marqusee E; Xiang P; Altshuler B; Haase J; Barletta JA; Landa I; Alexander EK
Thyroid; 2023 Jun; 33(6):697-704. PubMed ID: 36960703
[No Abstract] [Full Text] [Related]
18. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
Walts AE; Mirocha JM; Bose S
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1749-56. PubMed ID: 25702102
[TBL] [Abstract][Full Text] [Related]
19. Diffuse Sclerosing Papillary Thyroid Carcinoma: Clinicopathological Characteristics and Prognostic Implications Compared with Classic and Tall Cell Papillary Thyroid Cancer.
Scholfield DW; Fitzgerald CW; Alzumaili B; Eagan A; Xu B; Martinez G; Tuttle RM; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein RA; Ganly I
Ann Surg Oncol; 2023 Aug; 30(8):4761-4770. PubMed ID: 37154968
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer.
Sullivan MC; Graham PH; Alexander EK; Ruan DT; Nehs MA; Gawande AA; Moore FD; Howitt BE; Strickland KC; Krane JF; Barletta JA; Cho NL
J Am Coll Surg; 2017 Jun; 224(6):1021-1027. PubMed ID: 28017809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
